Oral bisphosphonates and risk of atrial fibrillation and flutter in women: A self-controlled case-series safety analysis

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Grosso, Anthony ^a,b   Douglas, Ian ^c   Hingorani, Aroon ^b   MacAllister, Raymond ^b   Smeeth, Liam ^c  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DIGOXIN; RISEDRONIC ACID; BONE DENSITY CONSERVATION AGENT; DRUG DERIVATIVE; ETIDRONIC ACID;

AGED; ARTICLE; DRUG EXPOSURE; DRUG RESEARCH; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PHARMACEUTICAL CARE; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; TREATMENT DURATION; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; FACTUAL DATABASE; MIDDLE AGED; RISK; TIME;

AGED; AGED, 80 AND OVER; ALENDRONATE; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DIPHOSPHONATES; DRUG TOXICITY; ETIDRONIC ACID; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RISK; TIME FACTORS;

EID: 62749177553     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004720     Document Type: Article

References (20)

1. Majumdar SR (2008) Oral bisphosphonates and atrial fibrillation. BMJ Apr 12; 336(7648): 784-5.
2. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, et al. (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med May 3; 356(18): 1809-22.
3. Cummings SR, Schwartz AV, Black DM (2007) Alendronate and atrial fibrillation. N Engl J Med May 3; 356(18): 1895-6.
4. Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM (2008) Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med Apr 28; 168(8): 826-31.
5. Karam R, Camm J, McClung M (2007) Yearly zoledronic acid in postmenopausal osteoporosis. N Engl J Med Aug 16; 357(7): 712-3.
6. Sorensen HT, Christensen S, Mehnert F, Pedersen L, Chapurlat RD, et al. (2008) Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ Apr 12; 336(7648): 813-6.
7. MHRA Drug Safety Update July 2008; Vol 1, issue 12: 4. MHRA 2008.
8. Farrington P, Pugh S, Colville A, Flower A, Nash J, et al. (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/ pertussis and measles/mumps/rubella vaccines. Lancet Mar 4; 345(8949): 567-9.
9. Whitaker H (2008) The self controlled case series method. BMJ Aug 28; 337(aug28_2): a1069.
10. General Practice Research Database. http://www.gprd.com/home/. Accessed 20 May 2008.
11. Frost L, Vestergaard P (2004) Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med Oct 11; 164(18): 1993-8.
12. Farrington CP, Nash J, Miller E (1996) Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol Jun 1; 143(11): 1165-73.
13. Farrington CP (1995) Relative incidence estimation from case series for vaccine safety evaluation. Biometrics Mar; 51(1): 228-35.
14. Hubbard R, Lewis S, West J, Smith C, Godfrey C, et al. (2005) Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax Oct; 60(10): 848-50.
15. Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L (2008) Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Br J Clin Pharmacol Nov; 66(5): 689-94.
16. Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, et al. (2002) Gastric and duodenal safety of daily alendronate. Arch Intern Med Apr 22; 162(8): 936-42.
17. Ruigomez A, Johansson S, Wallander M, Rodriguez L (2002) Incidence of chronic atrial fibrillation in general practice and its treatment pattern. Journal of Clinical Epidemiology 55(4): 358-63.
18. Mant J, Fitzmaurice DA, Hobbs FDR, Jowett S, Murray ET, et al. (2007) Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ Aug 25; 335(7616): 380.
19. Maclure M (1991) The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol Jan 15; 133(2): 144-53.
20. Whitaker H, Farrington CP, Spiessens B, Musonda P (2006) Tutorial in biostatistics: the self-controlled case series method. Stat Med May 30; 25(10): 1768-97.